| Value | ₹142.0 Cr |
|---|---|
| Execution period | Next 12 months |
NSE filing, NSE: OMFURN. Summary written from the filing by ALFA Finder's alert engine.
Omfurn India Ltd: key numbers
- Share price
- ₹42.65
- Market cap
- ₹50.22 Cr
- Revenue (annual)
- ₹86.41 Cr
- Net profit (annual)
- ₹6.30 Cr
- P/E (TTM)
- 8.0×Sector 35.3×
- Promoter holding
- 52.44%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omfurn India Ltd
All →Omfurn India H1 FY27 Results: Net Profit ₹2.5 Cr, Up 13.6% YoY
Omfurn India Ltd reported revenue from operations of ₹48.6 Cr (+47.3% YoY) and net profit of ₹2.5 Cr (+13.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.5 Cr · +13.6% YoY
Omfurn India Other Announcement
Omfurn India Limited filed its Regulation 74(5) compliance certificate for the quarter ended 30th September, 2026.
Omfurn India Annual General Meeting
Omfurn India Limited conducted its 29th Annual General Meeting on September 22, 2026, approving resolutions including financial statements and director remuneration revisions.
Omfurn India Other Announcement
Omfurn India Limited has issued a letter to shareholders providing the web-link to access the Annual Report 2025-26 and the Notice of the 29th AGM.
Omfurn India Annual General Meeting
Omfurn India Limited has issued a notice for its 29th Annual General Meeting scheduled for September 22, 2026, to transact ordinary and special business.
Omfurn India Bags ₹38.88 Cr Order
Omfurn India Limited secured various orders worth ₹38.88 Crore from Oberoi Realty Limited and its subsidiary. The projects involve supplying pre-finished wooden doors and installation.
- Value
- ₹38.88 Cr
- Execution
- By December 31, 2026
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.